Associate clinical Professor Surgery/Urology
Director of the prostate cancer fellowship program
University of Colorado Denver School of Medicine
The treatment options available for early stage organ-confined and low risk prostate cancer have been controversial.
A substantial number of men diagnosed with prostate cancer are over treated.
One out of ten of these men will die from prostate cancer.
Widespread screening has been cited as a cause of over diagnosis of the disease.